FIRST MANHATTAN CO. LLC. - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 95 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2015$21,000
-61.8%
2,940
-3.9%
0.00%
Q2 2015$55,000
-22.5%
3,060
-32.5%
0.00%
Q1 2015$71,000
-98.1%
4,530
-98.3%
0.00%
-100.0%
Q4 2014$3,800,000
-49.0%
268,580
-38.4%
0.02%
-48.8%
Q3 2014$7,449,000
-44.3%
435,880
-2.9%
0.04%
-49.4%
Q2 2014$13,367,000
-58.1%
448,887
-56.4%
0.08%
-59.5%
Q1 2014$31,867,000
+40.5%
1,029,977
+61.9%
0.21%
+40.0%
Q4 2013$22,674,000
+195.6%
636,030
+238.9%
0.15%
+177.8%
Q3 2013$7,671,000
+950.8%
187,700
+838.5%
0.05%
+980.0%
Q2 2013$730,00020,0000.01%
Other shareholders
THERAVANCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders